How to Pitch an Antibiotic Stewardship Program to the Hospital C-Suite

被引:39
作者
Spellberg, Brad [1 ,2 ]
Bartlett, John G. [3 ]
Gilbert, David N. [4 ]
机构
[1] Univ Southern Calif, Keck Sch Med, LAC USC Med Ctr, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
[4] Providence Portland Med Ctr, Div Infect Dis, Portland, OR USA
关键词
Antibiotic stewardship program; business plan; C-suite; cost efficacy; hospital; COMMUNITY-ACQUIRED PNEUMONIA;
D O I
10.1093/ofid/ofw210
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hospitals will soon require antibiotic stewardship programs. Infectious diseases specialists must craft business plans to engage hospital leadership to fund such programs. In this article, we review key cost and revenue elements that should be covered in such plans. Society is placing increasing emphasis on the importance of antimicrobial stewardship programs (ASPs). New regulatory standards require hospitals to implement ASPs. Infectious Diseases (ID) specialists will need to help design and implement such programs at hospitals. A critical component of establishing such programs is submitting a business plan to hospital leadership justifying the cost and structure of the ASP and explaining what benefits the hospital will gain in return. In this article, we explore typical elements of such business plans and describe how hospital leadership may evaluate and determine the value of such plans. Understanding hospital costs and revenue models is critical to creating a viable and realistic business plan to support ASPs.
引用
收藏
页数:5
相关论文
共 11 条
[1]  
[Anonymous], 2016, NEW ANT STEW STAND P
[2]  
[Anonymous], 2015, National action plan for combating antibiotic resistant bacteria
[3]  
[Anonymous], 2016, ANT STEW PLAYB
[4]   Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial [J].
Branche, Angela R. ;
Walsh, Edward E. ;
Vargas, Roberto ;
Hulbert, Barbara ;
Formica, Maria A. ;
Baran, Andrea ;
Peterson, Derick R. ;
Falsey, Ann R. .
JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (11) :1692-1700
[5]  
Centers for Medicare and Medicaid Services, CMS PROP RUL PROH DI
[6]   The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia [J].
Gelfer, Gita ;
Leggett, James ;
Myers, Jillian ;
Wang, Luan ;
Gilbert, David N. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (04) :400-406
[7]   The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia [J].
Gilbert, David ;
Gelfer, Gita ;
Wang, Lian ;
Myers, Jillian ;
Bajema, Kristina ;
Johnston, Michael ;
Leggett, James .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (01) :102-107
[8]   Where Do We Go From Here? [J].
Gilbert, David N. .
JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (11) :1687-1689
[9]  
Gold M, 1996, COST EFFECTIVENESS H
[10]  
PETITT I, 1994, METAANALYSIS DECISIO